Latest News and Events
Filter by
Selections
December 2, 2019
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
Read MoreNovember 26, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences
Read MoreNovember 18, 2019
Arrowhead Presents New Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at AHA Scientific Sessions 2019
Read MoreNovember 8, 2019
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019
Read MoreOctober 31, 2019
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ENaC at the North American Cystic Fibrosis Conference
Read MoreOctober 18, 2019